Implementation of pharmacist-prescribed contraceptive services: A case series of early adopters.
Jennifer A Campi, Sally Rafie, Jenny L Newlon...
https://pubmed.ncbi.nlm.nih.gov/39420991/Actively Recruiting
Led by EMPOWERX INC · Updated on 2025-12-04
150
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether using the HAPPI software can improve how pharmacists provide birth control services and how easily patients can access these services. This trial focuses on comparing pharmacist implementation and patient access with and without the HAPPI software to see if it offers improvements. The study involves 15 community pharmacies that will first continue their usual birth control services for several months without the software. Then, the HAPPI software will be introduced to replace previous paper or electronic processes as pharmacists continue providing birth control services. Outcomes during the control and intervention periods will be compared. Participants include pharmacists who provide birth control services and patients who receive these services at participating pharmacies. Researchers will measure aspects such as the number of pharmacists and pharmacy staff involved, payment methods like cash or insurance billing, and overall access to care during the study period of up to 5 months. The study is sponsored by EMPOWERX INC and runs through August 2026.
CONDITIONS
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
J
Jenny L Newlon, PharmD, PhD
S
Sally Rafie, PharmD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
EMPOWERX INC
Lead Sponsor
Purdue University
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | HAPPI Software in Community Pharmacies | Standard Pharmacy Workflow |
|---|---|---|
| What is it? | Birth control services provided by pharmacists in community pharmacies using the HAPPI software platform to support service delivery, documentation, and access. | Birth control services provided by pharmacists using standard workflows, such as paper-based protocols or conventional electronic record systems, before HAPPI software. |
| Role in the trial | Tested implementation in the trial group; evaluated for feasibility, service delivery, provider experience, and outcomes at participating pharmacies. | Represents pre-intervention or routine care approaches as a comparator for implementation evaluations. |
| Primary use or purpose | Intended to support and streamline pharmacist-prescribed birth control access, record-keeping, insurance billing, and patient engagement through digital tools. | Pharmacist assessment and provision of contraception using manual or legacy electronic processes to determine eligibility and document counseling, following state or pharmacy protocols. |
| How is it performed? | Pharmacists use the HAPPI software in the pharmacy setting to document patient encounters, screen eligibility, prescribe contraceptives, and manage service billing. | Pharmacists complete the prescribing and documentation process using paper forms or established electronic records, generally without a dedicated contraception software platform. |
| Evidence status | Evidence limited to current implementation study, with no published patient- or pharmacy-level outcome results at this time. | Supported by published case series and research in early-adopter states documenting feasibility, acceptability, and service outcomes in real-world implementation. |
| Important limitations | Implementation is limited to select sites and early phases; no comparative patient outcome data are published yet, and technology adoption may be influenced by local policies and training. | Challenges include variation in workflow, paper/electronic system limitations, pharmacist training requirements, and inconsistency in insurance billing and patient engagement; broader generalizability can vary across settings. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) to confirm eligibility
Duration - Several months
Participants receive birth control services as usual without the HAPPI software.
Participants receive routine pharmacy visits as needed for birth control services
Duration - Several months
Participants receive birth control services using the HAPPI software instead of previous paper or electronic processes.
Participants receive routine pharmacy visits as needed for birth control services using the software
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jennifer A Campi, Sally Rafie, Jenny L Newlon...
https://pubmed.ncbi.nlm.nih.gov/39420991/Jenny L Newlon, Jennifer A Campi, Sally Rafie...
https://pubmed.ncbi.nlm.nih.gov/39512515/EMPOWERX INC
Lead Sponsor
Purdue University
Collaborating Sponsor